ATOS
NASDAQ · Biotechnology
Atossa Therapeutics Inc
$5.34
+0.01 (+0.19%)
Open$5.33
Previous Close$5.33
Day High$5.54
Day Low$5.21
52W High$8.41
52W Low$5.48
Volume—
Avg Volume111.2K
Market Cap45.99M
P/E Ratio38.26
EPS$0.17
SectorBiotechnology
Analyst Ratings
Strong Buy
10 analysts
Price Target
+57.7% upside
Current
$5.34
$5.34
Target
$8.42
$8.42
$5.85
$8.42 avg
$9.99
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 21.66M | 19.11M | 19.03M |
| Net Income | -1,423,753 | -1,667,488 | -1,447,772 |
| Profit Margin | -6.6% | -8.7% | -7.6% |
| EBITDA | -1,912,051 | -1,729,452 | -1,852,839 |
| Free Cash Flow | -992,506 | -967,985 | -917,697 |
| Rev Growth | +8.7% | -4.8% | +0.2% |
| Debt/Equity | 0.16 | 0.13 | 0.13 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |